MRI in Preclinical Drug Development

互联网2014-02-13

394

This chapter outlines the challenges that the pharmaceutical industry faces during the course of drug development and discusses the role of magnetic resonance imaging in preclinical drug discovery.

相关产品推荐

nfsA/nfsA蛋白Recombinant Escherichia coli Oxygen-insensitive NADPH nitroreductase (nfsA)重组蛋白Modulator of drug activity A蛋白

￥2328

MRI-1867，阿拉丁

￥3999.90

PKG drug G1，374703-78-3，阿拉丁

￥974.90

ABCC1抗体ABCC1一抗抗体Multiple drug resistance protein 1 antibody抗体ABCC1 Antibody抗体

￥1100

SUSD6抗体SUSD6兔多抗抗体Drug-activated gene overexpressed protein antibody抗体SUSD6 Antibody抗体

￥440